Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment

• Published in: Drug safety Vol. 11; no. 3; p. 179
• Main Authors: Gennari, C, Nuti, R, Agnusdei, D, Camporeale, A, Martini, G
• Format: Journal Article
• Language: English
• Published: New Zealand 01.09.1994
• Subjects: Bone Development - drug effects; Bone Remodeling - drug effects; Calcitonin - administration & dosage; Calcitonin - adverse effects; Calcitonin - therapeutic use; Calcium - administration & dosage; Calcium - adverse effects; Calcium - therapeutic use; Diphosphonates - administration & dosage; Diphosphonates - adverse effects; Diphosphonates - therapeutic use; Drug Therapy, Combination; Estrogen Replacement Therapy - adverse effects; Female; Fractures, Bone - prevention & control; Humans; Osteitis Deformans - drug therapy; Osteoporosis, Postmenopausal - drug therapy

Osteoporosis is a major public health problem occurring primarily among the postmenopausal population. Osteoporosis is a preventable disease, but despite several advances in its prevention, treatment of the established disease to date remains a major challenge to be managed by primary care physician...